Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jaad.2019.07.102 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Gender-Affirming Hormone Therapy With Estrogen Causing Gallstone Associated Acute Pancreatitis.
AACE Clin Case Rep
July 2024
Department of Internal Medicine, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri.
Background/objective: Although estrogen is one of the main agents used to treat transgender women, there are few reports of acute pancreatitis (AP) of this illness in this group. The objective of this report is to describe a transgender woman who developed AP in the setting of estrogen treatment and gallstone disease.
Case Report: A 38-year-old transgender woman presented with severe abdominal pain and vomiting.
Add-on multidrug treatment based on quadruple therapy successfully treated worsening heart failure caused by anthracycline-induced cardiomyopathy in a survivor of cancer as a young adult: a case report.
BMC Cardiovasc Disord
September 2024
Department of Cardiology, Niigata City General Hospital, 463-7, Shumoku, Chuo-ku, Niigata, 950-1197, Japan.
Article Synopsis
- * A case study featured a cancer survivor who experienced heart failure 20 years after treatment, and showed notable improvement when a combination of heart medications, including vericiguat, were introduced.
- * The results suggest that this multidrug approach, including the additions of vericiguat and ivabradine, could effectively manage worsening heart failure in young cancer survivors suffering from severe
Association of spironolactone use with risk of urinary tract cancer in the general population: A matched population-based cohort study.
PLoS One
March 2024
Department of Radiation Oncology, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan.
Purpose: The correlation between spironolactone usage and cancer risk has sparked interest. The objective of this study is to examine the association between spironolactone use and the incidence of urinary tract cancer in the general population.
Methods: We conducted a matched population-based cohort study.
Retrospective study on the short-term efficacy of different doses of Spironolactone in patients with heart failure of ischemic cardiomyopath and the influence of ventricular remodeling markers.
Am J Cardiovasc Dis
February 2024
Department of Cardiology, The Second Affiliated Hospital, Army Medical University (Third Military Medical University) Chongqing 400037, China.
Objective: To evaluate the impact of varying dosages of Spironolactone on the short-term effectiveness and ventricular remodeling indicators in patients with Heart Failure of Ischemic Cardiomyopathy (HFIC).
Methods: A cohort of 141 HFIC patients, admitted to our hospital between October 2018 and February 2023, were enrolled for this study. Alongside the standard treatment for Chronic Congestive Heart Failure (CHF), these patients were randomly assigned to either a low-dose (20 mg/d, N=70) or a high-dose (60 mg/d, N=71) Spironolactone group.
Insulin sensitisation for polycystic ovary syndrome: High-dose monotherapy versus low-dose combination.
Clin Endocrinol (Oxf)
March 2024
Endocrinology Department, Institut de Recerca Sant Joan de Déu, University of Barcelona, Esplugues, Barcelona, Spain.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!